INMUNE BIO INC. Prepaid Expense and Other Assets, Current
INMUNE BIO INC. (INMB) had Prepaid Expense and Other Assets, Current of $621.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $621.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $694.00K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $595.00K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $472.00K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $621.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $694.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $595.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $472.00K 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $505.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $207.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $331.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $864.00K 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $1.01M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $1.11M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.51M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $1.53M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $2.71M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $35.00K 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $4.03M 10-K · filed 2024-03-28 | $34.00K 10-K · filed 2023-03-02 |
| 2021-12-31 | $14.00K 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |